Brian Montague, DO
Professor, Medicine-Infectious Disease
Medical School
- DO, University of North Texas Health Science Center at Fort Worth Texas College of Osteopathic Medicine at Fort Worth (2003)
Graduate Schools
- MS, University of Colorado Health Sciences Center (1997)
- MPH, University of North Texas Health Science Center At Fort Worth (2001)
Undergraduate School
- BS, Metropolitan State College of Denver (CO) (1992)
Internship
- Yale-New Haven Medical Center (Waterbury) Program (2003)
Residency
- Yale-New Haven Medical Center (Waterbury) Program, Chief Resident, Internal Medicine (2007)
Fellowships
- University of Colorado, Infectious Disease (2017)
Department
Medicine-Infectious DiseaseProfessional Titles
- Professor of Medicine
- Medical Director, Division of Occupational Health, Department of Environmental Health and Safety
- Physician Informaticist
- Medical Director Transplant Infectious Disease
Research Interests
My research interests include the epidemiology of and immune response to viral respiratory infections. I have additional interests in the natural history and treatment of infections in immunocompromised hosts and the use of clinical information systems to optimize care.Publications
- Levi ME, Montague BT, Thurstone C, Kumar D, Huprikar SS, Kotton CN. Marijuana use in transplantation: A call for clarity. Clin Transplant. 2018 Dec 2:e13456. doi: 10.1111/ctr.13456. [Epub ahead of print]
- Montague BT, John B, Sammartino C, Costa M, Fukuda D, Solomon L, Rich JD. Use of viral load surveillance data to assess linkage to care for persons with HIV released from corrections..PLoS One. 2018 Feb 12;13(2):e0192074. doi: 10.1371/journal.pone.0192074. eCollection 2018.
- Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019 Sep 20. [Epub ahead of print] PubMed PMID: 31538963
- Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2019 Sep 5. [Epub ahead of print] PubMed PMID: 31486710
- Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. J Antimicrob Chemother. 2019 Aug 1;74(8):2405-2416. PubMed PMID: 31322694
- Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs. Open Forum Infect Dis. 2019 Jul;6(7):ofz274. PubMed PMID: 31281868
- Snyder BM, Montague BT, Anandan S, Madabhushi AG, Pragasam AK, Verghese VP, Balaji V, Simões EAF. Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae. Epidemiol Infect. 2019 Jan;147:e137. PubMed PMID: 30869056
- Levi ME, Montague BT, Thurstone C, Kumar D, Huprikar SS, Kotton CN. Marijuana use in transplantation: A call for clarity. Clin Transplant. 2019 Feb;33(2):e13456. PubMed PMID: 30506888
- Hazlett C, Wulf DA, Pasaniuc B, Arah OA, Erlandson KM, Montague BT. Credible learning of hydroxychloroquine and dexamethasone effects on COVID-19 mortality outside of randomized trials. medRxiv. 2020 Dec 8. PubMed PMID: 33330889
- Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 Sep 2;222(Supplement_5):S486-S493. PubMed PMID: 32877543
- Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE. Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail. AIDS Behav. 2020 Aug;24(8):2430-2441. PubMed PMID: 32006154
- Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2020 Jun;26(6):776-783. PubMed PMID: 31486710
- Montague BT, Wipperman MF, Hooper AT, Hamon SC, Crow R, Elemo F, Hersh L, Langdon S, Hamilton JD, O'Brien MP, Simões EAF. Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders. J Infect Dis. 2021 Oct 12. [Epub ahead of print] PubMed PMID: 34636907
- Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 Jul 6;326(1):46-55. PubMed PMID: 34081073
- Jaenisch T, Lamb MM, Gallichotte EN, Adams B, Henry C, Riess J, van Sickle JT, Hawkins KL, Montague BT, Coburn C, Conners Bauer L, Kovarik J, Hernandez MT, Bronson A, Graham L, James S, Hanenberg S, Kovacs J, Spencer JS, Zabel M, Fox PD, Pluss O, Windsor W, Winstanley G, Olson D, Barer M, Berman S, Ebel G, Chu M. Investigating transmission of SARS-CoV-2 using novel face mask sampling: a protocol for an observational prospective study of index cases and their contacts in a congregate setting. BMJ Open. 2022 Nov 23;12(11):e061029. PubMed PMID: 36418127
- Montague BT, Wipperman MF, Chio E, Crow R, Hooper AT, O'Brien MP, Simões EAF. Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders. Sci Rep. 2022 Sep 2;12(1):14932. PubMed PMID: 36056118
- Montague BT, Wipperman MF, Hooper AT, Hamon SC, Crow R, Elemo F, Hersh L, Langdon S, Hamilton JD, O'Brien MP, Simões EAF. Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders. J Infect Dis. 2022 Feb 15;225(4):578-586. PubMed PMID: 34636907
- Wolf AB, Money KM, Chandnani A, Daley CL, Griffith DE, Chauhan L, Coffman N, Piquet AL, Tyler KL, Zimmer SM, Montague BT, Mann S, Pastula DM. Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism. Emerg Infect Dis. 2023 Aug;29(8):1655-1658. PubMed PMID: 37486227
- Rigolon A, Németh J, Anderson-Gregson B, Miller AR, deSouza P, Montague B, Hussain C, Erlandson KM, Rowan SE. The neighborhood built environment and COVID-19 hospitalizations. PLoS One. 2023;18(6):e0286119. PubMed PMID: 37314984
Practice Locations
UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus1635 Aurora Ct
Aurora, CO 80045
720-848-0000
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties- Infectious Disease, Board Certification (2017)
- Internal Medicine (2006, 2016)
- Clinical Informatics (2020)
- T32: Infectious Complications of Substance Use, Other (2009)
- Infections
- Infections - Bacterial Infections
- Infections - Fungal Infections
- Infections - Influenza
- Infections - Pneumonia
- Infections - Sexually Transmitted Diseases
- Infections - Viral Infections
- Organ Transplant
Clinical Interests
I provide inpatient and outpatient consultations for patients who are undergoing or who have undergone solid organ or cell transplantation. I additionally provide comprehensive primary care for patients living with HIV as well as infectious disease consultation for patients with complex and atypical infections, viral hepatitis, travel-associated infection risk and travel-related infections.
I provide inpatient and outpatient consultations for patients who are undergoing or who have undergone solid organ or cell transplantation. I additionally provide comprehensive primary care for patients living with HIV as well as infectious disease consultation for patients with complex and atypical infections, viral hepatitis, travel-associated infection risk and travel-related infections.